Codice QR

Continuum of Core 1 biomarkers in preclinical Alzheimer’s disease

Abstract Background Biological Staging for Alzheimer’s disease (AD) in clinically unimpaired (CU) individuals is critical for early detection efforts. In this study, we evaluated whether Core 1 biomarkers (plasma p-tau217 and amyloid-PET) within Biological Stage A, the earliest biological stage of A...

Descrizione completa

Salvato in:
Autori principali: Leonardino A. Digma, Christina B. Young, Joseph R. Winer, Karly A. Cody, Kyan Younes, Jintao Sheng, Philip S. Insel, Robert A. Rissman, Reisa Sperling, Elizabeth C. Mormino
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2026-04-01
Serie:Alzheimer’s Research & Therapy
Soggetti:
Biological staging
preclinical Alzheimer’s disease
p-tau217
tau-PET
Accesso online:https://doi.org/10.1186/s13195-026-02044-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi